Literature DB >> 2828619

Application of the message-address concept in the design of highly potent and selective non-peptide delta opioid receptor antagonists.

P S Portoghese1, M Sultana, H Nagase, A E Takemori.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 2828619     DOI： 10.1021/jm00397a001

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  33 in total

1.  Opioid delta agonists and endogenous enkephalins induce different emotional reactivity than mu agonists after injection in the rat ventral tegmental area.

Authors:  G Calenco-Choukroun; V Daugé; G Gacel; J Féger; B P Roques
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Comparative conformational analysis of [D-Pen2,D-Pen5]enkephalin (DPDPE): a molecular mechanics study.

Authors:  B C Wilkes; P W Schiller
Journal:  J Comput Aided Mol Des       Date:  1991-08       Impact factor: 3.686

3.  14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: design, synthesis, and biological studies.

Authors:  Guo Li; Lindsey C K Aschenbach; Hengjun He; Dana E Selley; Yan Zhang
Journal:  Bioorg Med Chem Lett       Date:  2008-12-29       Impact factor: 2.823

4.  Stress-induced activation of ventral tegmental mu-opioid receptors reduces accumbens dopamine tone by enhancing dopamine transmission in the medial pre-frontal cortex.

Authors:  Emanuele Claudio Latagliata; Alessandro Valzania; Tiziana Pascucci; Paolo Campus; Simona Cabib; Stefano Puglisi-Allegra
Journal:  Psychopharmacology (Berl)       Date:  2014-03-29       Impact factor: 4.530

Review 5.  Understanding Peptide Binding in Class A G Protein-Coupled Receptors.

Authors:  Irina G Tikhonova; Veronique Gigoux; Daniel Fourmy
Journal:  Mol Pharmacol       Date:  2019-07-10       Impact factor: 4.436

6.  A proposal for the molecular basis of mu and delta opiate receptor differentiation based on modeling of two types of cyclic enkephalins and a narcotic alkaloid.

Authors:  A Michel; G Villeneuve; J DiMaio
Journal:  J Comput Aided Mol Des       Date:  1991-12       Impact factor: 3.686

7.  Development of novel lipophilic derivatives of DADLE (leucine enkephalin analogue): intestinal permeability characateristics of DADLE derivatives in rats.

Authors:  T Uchiyama; A Kotani; H Tatsumi; T Kishida; A Okamoto; N Okada; M Murakami; T Fujita; Y Fujiwara; Y Kiso; S Muranishi; A Yamamoto
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

8.  Affinity profiles of novel delta-receptor selective benzofuran derivatives of non-peptide opioids.

Authors:  M Spetea; S T Nevin; S Hosztafi; A Z Rónai; G Tóth; A Borsodi
Journal:  Neurochem Res       Date:  1998-09       Impact factor: 3.996

9.  In vitro and in vivo pharmacological profile of the 5-benzyl analogue of 14-methoxymetopon, a novel mu opioid analgesic with reduced propensity to alter motor function.

Authors:  Mariana Spetea; Catalina R Bohotin; Muhammad F Asim; Kurt Stübegger; Helmut Schmidhammer
Journal:  Eur J Pharm Sci       Date:  2010-06-18       Impact factor: 4.384

10.  Syntheses of novel high affinity ligands for opioid receptors.

Authors:  Mark P Wentland; Rongliang Lou; Qun Lu; Yigong Bu; Christoph Denhardt; Jin Jin; Rakesh Ganorkar; Melissa A VanAlstine; Chengyun Guo; Dana J Cohen; Jean M Bidlack
Journal:  Bioorg Med Chem Lett       Date:  2009-02-25       Impact factor: 2.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.